Skip to main content
Journal ArticleOPEN ACCESS

Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.

  • Seibel M
  • Woitge H
  • Pecherstorfer M
  • et al.
The Journal of Clinical Endocrinology & Metabolism (1996) 81(9) 3289-3294
DOI: 10.1210/jcem.81.9.8784085
N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Bone sialoprotein (BSP) is a phosphorylated glycoprotein with a M

Cite

CITATION STYLE

APA

Seibel, M. J., Woitge, H. W., Pecherstorfer, M., Karmatschek, M., Horn, E., Ludwig, H., … Ziegler, R. (1996). Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. The Journal of Clinical Endocrinology & Metabolism, 81(9), 3289–3294. https://doi.org/10.1210/jcem.81.9.8784085

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free